Skip to main content

ImmunityBio, Inc.

IBRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001326110

In the last 90 days, ImmunityBio, Inc. insiders filed 0 open-market purchases and 3 sales; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.

13F holders, Q4 2022

Institutional positions in ImmunityBio, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
140
+16 vs. Q3 2022
Shares held
50.0M
+10.5M (+26.7%) vs. Q3 2022
Total value
$256.0M
+$59.8M (+30.5%) vs. Q3 2022
New holders
27
43 more added
Sold out
11
41 more reduced

2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 140 institutions
Q1 2021: 116 institutionsQ2 2021: 118 institutionsQ3 2021: 121 institutionsQ4 2021: 141 institutionsQ1 2022: 149 institutionsQ2 2022: 132 institutionsQ3 2022: 126 institutionsQ4 2022: 140 institutionsQ1 2023: 147 institutionsQ2 2023: 118 institutionsQ3 2023: 132 institutionsQ4 2023: 148 institutionsQ1 2024: 166 institutionsQ2 2024: 194 institutionsQ3 2024: 182 institutionsQ4 2024: 202 institutionsQ1 2025: 211 institutionsQ2 2025: 242 institutionsQ3 2025: 264 institutionsQ4 2025: 278 institutionsQ1 2026: 386 institutionsQ2 2026: 405 institutions
Value heldQ4 2022: $256.0M
Q1 2021: $378.9MQ2 2021: $390.1MQ3 2021: $310.9MQ4 2021: $209.7MQ1 2022: $199.8MQ2 2022: $123.1MQ3 2022: $196.3MQ4 2022: $256.0MQ1 2023: $84.1MQ2 2023: $108.7MQ3 2023: $84.1MQ4 2023: $288.9MQ1 2024: $356.9MQ2 2024: $391.1MQ3 2024: $255.6MQ4 2024: $211.8MQ1 2025: $239.4MQ2 2025: $327.9MQ3 2025: $352.1MQ4 2025: $338.3MQ1 2026: $1.36BQ2 2026: $1.76B
Institutions holding IBRX and their total value by quarter
QuarterHoldersValue
Q2 2026405$1.76B
Q1 2026386$1.36B
Q4 2025278$338.3M
Q3 2025264$352.1M
Q2 2025242$327.9M
Q1 2025211$239.4M
Q4 2024202$211.8M
Q3 2024182$255.6M
Q2 2024194$391.1M
Q1 2024166$356.9M
Q4 2023148$288.9M
Q3 2023132$84.1M
Q2 2023118$108.7M
Q1 2023147$84.1M
Q4 2022140$256.0M
Q3 2022126$196.3M
Q2 2022132$123.1M
Q1 2022149$199.8M
Q4 2021141$209.7M
Q3 2021121$310.9M
Q2 2021118$390.1M
Q1 2021116$378.9M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding ImmunityBio, Inc.; share changes are against Q3 2022.

Institutions holding IBRX in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
State of Wisconsin Investment Board114,677$581.4K0.00%−123,979−51.9%Reduced
National Bank of Canada132,100$669.7K0.00%+130,300+7,238.9%Added
California State Teachers Retirement System136,986$694.5K0.00%+1,949+1.4%Added
UBS Asset Management Americas Inc147,198$746.3K0.00%+11,843+8.7%Added
Price T Rowe Associates Inc149,958$760.0K0.00%−7,908−5.0%Reduced
Citadel Advisors LLC153,020$775.8K0.00%−395,134−72.1%Reduced
Schonfeld Strategic Advisors LLC155,203$786.9K0.01%+155,203New
Putnam Investments LLC171,939$871.7K0.00%−92−0.1%Reduced
Royal Bank of Canada185,551$941.0K0.00%+143,844+344.9%Added
Clearwater Capital Advisors, LLC185,911$942.6K0.12%00.0%Unchanged
DekaBank Deutsche Girozentrale196,200$951.0K0.00%00.0%Unchanged
Citigroup Inc212,605$1.08M0.00%−161,039−43.1%Reduced
Alliancebernstein L.P.225,758$1.14M0.00%00.0%Unchanged
Winning Points Advisors, LLC242,586$1.23M1.56%−8,970−3.6%Reduced
Barclays PLC256,365$1.30M0.00%+3,335+1.3%Added
Swiss National Bank290,000$1.47M0.00%+8,900+3.2%Added
Group One Trading, L.P.321,093$1.63M0.06%−59,595−15.7%Reduced
Invesco Ltd.332,856$1.69M0.00%+291,110+697.3%Added
HarbourVest Partners LLC335,709$1.70M0.57%00.0%Unchanged
UBS Group AG368,603$1.87M0.00%+252,685+218.0%Added
Susquehanna International Group, LLP421,999$2.14M0.00%−208,767−33.1%Reduced
Bank of New York Mellon Corp449,949$2.28M0.00%+8,451+1.9%Added
Rafferty Asset Management, LLC471,523$2.39M0.02%+67,083+16.6%Added
Morgan Stanley544,158$2.76M0.00%−97,655−15.2%Reduced
Allen Holding Inc687,571$3.49M0.49%00.0%Unchanged
Credit Suisse AG689,734$3.50M0.00%−8,318−1.2%Reduced
Charles Schwab Investment Management Inc723,519$3.67M0.00%+11,301+1.6%Added
Nuveen Asset Management, LLC248,898$3.83M0.00%−21,085−7.8%Reduced
Bank of America Corp762,794$3.87M0.00%+469,444+160.0%Added
Northern Trust Corp815,273$4.13M0.00%+4,384+0.5%Added
Pictet Asset Management SA846,120$4.29M0.01%+207,943+32.6%Added
Balyasny Asset Management LLC896,961$4.55M0.02%+849,054+1,772.3%Added
Goldman Sachs Group Inc1,151,724$5.84M0.00%+585,881+103.5%Added
JPMorgan Chase & Co1,533,127$7.77M0.00%−30,136−1.9%Reduced
Sheets Smith Wealth Management1,544,048$7.83M1.23%+1,336,122+642.6%Added
Geode Capital Management, LLC2,030,492$10.3M0.00%+108,903+5.7%Added
State Street Corp6,736,051$34.2M0.00%+86,720+1.3%Added
BlackRock Inc.7,020,134$35.6M0.00%+802,935+12.9%Added
CVI Holdings, LLC7,609,166$38.6M4.92%+7,609,166New
Vanguard Group Inc8,255,246$41.9M0.00%+175,705+2.2%Added
Parallel Advisors, LLC0$00.00%−275−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−678,504−100.0%Sold out
Millennium Management LLC0$00.00%−399,271−100.0%Sold out
Oracle Investment Management Inc0$00.00%−315,322−100.0%Sold out
BNP Paribas Arbitrage, SA0$00.00%−148,282−100.0%Sold out
Ensign Peak Advisors, Inc0$00.00%−57,690−100.0%Sold out
Man Group plc0$00.00%−22,600−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−20,700−100.0%Sold out
Quantbot Technologies LP0$00.00%−12,424−100.0%Sold out
Signaturefd, LLC0$00.00%−3,845−100.0%Sold out
West Oak Capital, LLC0$00.00%−1,500−100.0%Sold out
CPWM, LLC––––Not filed
Covington Capital Management––––Not filed